cross-posted from: https://lemm.ee/post/64477597

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • Eternal throwback to the etchics essay I wrote at uni when starting to study genetics, late 90s.

    The conclusions I got to then kept me safe from this grift, but I am sure my extended family from one side that is obsessed with their kulak heritage has sent in all the samples to justify their rabid nationalism.